# Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/two-phase-3-trials-of-lebrikizumab-for-moderate-to-severe-atopic-dermatitis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jonathan I. Silverberg,Emma Guttman‐Yassky,Diamant Thaçi,Alan D. Irvine,Linda Stein Gold,Andrew Blauvelt,Eric L. Simpson,Chia‐Yu Chu,Zhuqing Liu,Renata Gontijo Lima,Sreekumar Pillai,Julien Sénéschal |
| Citations | 329 |
| DOI | 10.1056/nejmoa2206714 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4324311526 |
| PMID | 36920778 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Jonathan I. Silverberg](https://scholariq.org/researchers/jonathan-i-silverberg/)
- [Alan D. Irvine](https://scholariq.org/researchers/alan-d-irvine/)
- [Chia‐Yu Chu](https://scholariq.org/researchers/chia-yu-chu/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

## Paper topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Food Allergy and Anaphylaxis Research](https://scholariq.org/topics/food-allergy-and-anaphylaxis-research/)
- [Mast cells and histamine](https://scholariq.org/topics/mast-cells-and-histamine/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.